Trelagliptin succinate

CAS No.	1029877-94-8	Cat. No.	BCP08138
Name	Trelagliptin succinate
Synonyms	SYR-472 succinate; SYR472 succinate; SYR 472 succinate;
Formula	C22H26FN5O6	M. Wt	475.47

Description	Trelagliptin is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D). Two Phase II clinical studies have been completed with Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus. Phase III clinical studies with trelagliptin in Japan to evaluate its safety and efficacy in a once-weekly oral treatment regimen. Currently, all available DPP-4 inhibitors are dosed once-daily. A once-weekly treatment, such as trelagliptin, would provide patients with a convenient treatment alternative and has the potential to improve treatment compliance.
Pathways	Protease/Metabolic Enzyme
Targets	DPP

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.